Xtant Medical Holdings, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in the development and distribution of innovative spinal and cranial surgical solutions. With a focus on regenerative medicine, Xtant Medical offers a range of core products, including allograft tissue and advanced surgical instruments, designed to enhance patient outcomes. Operating primarily in North America, Xtant Medical has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Renowned for its commitment to quality and innovation, the company continues to strengthen its position in the competitive landscape of orthopaedic and neurosurgical markets, making it a trusted partner for healthcare professionals worldwide.
How does Xtant Medical Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Xtant Medical Holdings, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Xtant Medical Holdings, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific climate commitments outlined in their reduction initiatives. As such, there are no reported figures for their carbon emissions in kg CO2e, nor are there established reduction targets or commitments to the Science Based Targets initiative (SBTi). In the absence of specific emissions data, it is essential to note that many companies in the medical and healthcare sectors are increasingly focusing on sustainability and climate action. This includes setting ambitious targets for reducing greenhouse gas emissions across various scopes, including Scope 1 (direct emissions), Scope 2 (indirect emissions from energy), and Scope 3 (indirect emissions from the supply chain). While Xtant Medical Holdings, Inc. has not disclosed any specific initiatives or targets, the industry context suggests a growing trend towards enhancing environmental responsibility and transparency in carbon management.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Xtant Medical Holdings, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.